Current directions in IBD therapy: what goals are feasible with biological modifiers?
Gastroenterology
.
2008 Nov;135(5):1442-7.
doi: 10.1053/j.gastro.2008.09.053.
Epub 2008 Oct 9.
Author
William J Sandborn
1
Affiliation
1
Inflammatory Bowel Disease Clinic, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905, USA. william@mayo.edu
PMID:
18848556
DOI:
10.1053/j.gastro.2008.09.053
No abstract available
Publication types
Review
MeSH terms
Biological Factors / therapeutic use*
Humans
Inflammatory Bowel Diseases / drug therapy*
Inflammatory Bowel Diseases / immunology
Practice Guidelines as Topic*
Remission Induction / methods
Substances
Biological Factors